General Announcement::Glenmark launches Tiogiva becoming one of the first companies in the UK

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
15-Jun-2021 13:44:46
Status
New
Announcement Sub Title
Glenmark launches Tiogiva becoming one of the first companies in the UK
Announcement Reference
SG210615OTHR72MN
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
15/06/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
Glenmark launches Tiogiva, becoming one of the first companies in the UK to launch a bioequivalent version of Tiotropium Bromide dry powder inhaler

Attachments

SGX PR 15062021.pdf
Total size =965K